Home Company In the Media Upcoming Events Board of Directors Management Team Medical Advisory Board

Go tab to… Home Company -   In tab the Media -   Upcoming Events -   Board of Directors -   Management Team -   Medical Advisory Board Technology Products tab -   Testimonials -   ActiPatch -   Smart tab Insole -   Allay -   RecoveryRx -   HealFast Clinical Evidence -   Pain Overview -   Published Clinical Literature -   Cell Studies -   Musculoskeletal Pain -   Menstrual Pain -   Postoperative Pain & Edema -   Chronic tab Wounds Distributors -   Distribution Opportunities -   Market Clearances Investors -   FDA Status -   Investors Financials -   Letter from the President -   Press Releases -   Investor Updates FAQ Contact
Home Company In the Media Upcoming Events Board of Directors Management Team Medical Advisory Board Technology Products Testimonials ActiPatch Smart Insole Allay RecoveryRx HealFast Clinical Evidence Pain Overview Published tab Clinical Literature Cell Studies Musculoskeletal Pain Menstrual Pain Postoperative Pain & Edema Chronic tab Wounds Distributors Distribution Opportunities Market Clearances Investors FDA Status Investors Financials Letter from the President Press Releases Investor Updates FAQ Contact
FREDERICK, MD, USA, March 20, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that the Depository Trust Company has determined to end the deposit transaction restriction (the Deposit Chill) it had previously placed on shares of BioElectronics. tab
The Company said it was notified of the Depository Trust Company s decision in a letter via email to James D. Pierce, Esq. of Sugarland, Texas has represented the corporation in this matter. The letter from DTC counsel Donald Maj said that the DTC has resumed accepting deposits of the Issue for deposits and book entry transfer services.
We are pleased that the DTC has decided to remedy this situation which has been an inconvenience and burden on our shareholders, said Richard Staelin, Chairman of the Board of BioElectronics Corporation and the Edward tab and Rose Donnell tab Professor of Business Administration at The Fuqua School of Business, Duke University.
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx Devices for chronic and post-operative wound care; Allay Menstrual Pain Therapy; and HealFast Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com .
In 2009, BioElectronics was a proud runner-up tab for the prestigious Wall Street Journal Technology Innovation Awards. In 2013, our ActiPatch Product was cited for Most Innovative New OTC Product runner up award from the OTC Bulletin, a leading UK-based Healthcare Marketing Publication.